TELMISARTAN
NDC 62135-535, TELMISARTAN, tablet, from Chartwell RX, LLC..
- Product NDC
- 62135-535
- Status
- Listed
- Labeler
- Chartwell RX, LLC.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078710
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TELMISARTAN20 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-535-30 | 62135053530 | 30 TABLET in 1 BOTTLE (62135-535-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/beaaf383-730f-4411-b5e7-15c32b53a338NADAC price for package 62135053530
GET /v1/drugs/nadac/62135053530
Use it
Look up 62135-535 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-535 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-535. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.